LATS protector, the human thyroid stimulator
Adams, D.D.
New Zealand Medical Journal 81(531): 22-23
1975
ISSN/ISBN: 0028-8446 PMID: 1055310 Document Number: 83876
Document emailed within 1 workday
Related Documents
Winand, R. 1970: Long-acting thyroid stimulator (LATS) in thyroid pathology Revue Medicale de Liege 25(15): 478-482O'Hearlihy, C. 1977: Neonatal thyrotoxicosis with long acting thyroid stimulator-protector Irish Medical Journal 70(4): 124-125
Gharib, H.; Mayberry, W.E. 1970: Diagnosis of Graves' ophthalmopathy without hyperthyroidism: long-acting thyroid stimulator (LATS) determination as laboratory adjunct Mayo Clinic Proceedings 45(6): 444-449
Kendall-Taylor, P.; Smith, B.R.; Munro, D.S. 1971: The interaction between thyroid tissue and the long-acting thyroid stimulator Quarterly Journal of Medicine 40(160): 564-565
Kobayashi, I.; Shoda, Y.; Kuwabara, A.; Okajima, F.; Kondo, Y. 1994: Assay of circulating thyroid stimulator determined by I- efflux Rinsho Byori. Japanese Journal of Clinical Pathology 42(9): 938-942
Gershanovich, M.L.; Filatova, L.V.; Ketlinskiĭ, S.A.; Simbirtsev, A.S. 2000: Betaleukin (human recombinant interleukin-1 beta)--a new effective leukopoiesis stimulant and protector in the combined chemotherapy of malignant tumors Voprosy Onkologii 46(3): 354-360
Yao, Z.Q.; Yang, W.S.; Chen, B.F.; Shang, P.; Zhang, W.B.; Chen, Y. 1993: Purification and characterization of human hepatic stimulator substance Chinese Medical Journal 106(7): 527-532
Ito, R.; Kitadai, Y.; Kyo, E.; Yokozaki, H.; Yasui, W.; Yamashita, U.; Nikai, H.; Tahara, E. 1993: Interleukin 1 alpha acts as an autocrine growth stimulator for human gastric carcinoma cells Cancer Research 53(17): 4102-4106
Nieda, M.; Juji, T.; Imao, S.; Minami, M. 1988: A role of HLA-DQ molecules of stimulator-adherent cells in the regulation of human autologous mixed lymphocyte reaction Journal of Immunology 141(9): 2975-2979
Letonturier, P.; Tourneur, R. 1975: An antibody called LATS La Nouvelle Presse Medicale 4(3): 177-179
Yamashita, K.; Kugai, N. 1981: Recent findings on TSH, LATS and TSI Nihon Rinsho. Japanese Journal of Clinical Medicine 39(9): 2949-2953
Skinnider, L.F.; McAskill, J. 1980: A comparison of phorbol myristate acetate with phytohemgglutinin as a stimulator of in vitro colony growth of peripheral human leucocytes Experimental Hematology 8(4): 477-483
Schemmel, K.; Weisbecker, L.; Norden, H.; Mokmol, V.; Becker, V.; Bindeballe, W. 1973: Identification of LATS as an antigen-antibody complex Acta Endocrinologica. Supplementum 173: 11
Kadyrova, D.A.; Atakhanova, B.A.; Maksumova, U.P.; Turakulov, I.K.; Shipitsyna, G.I. 1989: Thyroglobulin gene expression in human thyroid cells in various types of thyroid pathology Molekuliarnaia Biologiia 23(4): 1101-1106
Kakudo, K.; Vacca, L.L. 1983: Immunohistochemical study of substance P-like immunoreactivity in human thyroid and medullary carcinoma of the thyroid Journal of Submicroscopic Cytology 15(2): 563-568
Liu, B.; Kuang, A. 2012: Clinical application of recombinant human thyroid-stimulating hormone in management of differentiated thyroid carcinoma Sheng Wu Yi Xue Gong Cheng Xue Za Zhi 29(3): 588-592
Thomas-Morvan, C.; Nataf, B.; Tubiana, M. 1977: In vivo and organ culture studies of thyroid proteins and hormone synthesis in human thyroid cancer tissues Annales de Radiologie 20(8): 739-742
Fu, H.; Ma, C.; Tang, L.; Wu, F.; Liu, B.; Wang, H. 2015: Recombinant human thyrotropin versus thyroid hormone withdrawal in radioiodine remnant ablation for differentiated thyroid cancer: a meta-analysis Quarterly Journal of Nuclear Medicine and Molecular Imaging: Official Publication of the Italian Association of Nuclear Medicine and the International Association of Radiopharmacology and Section of the Society Of. 59(1): 121-128
Sawada, T.; Hashimoto, S. 2007: Human monoclonal antibody to B-lymphocyte stimulator (belimumab) and humanized anti-LFA-1 monoclonal antibodies (efalizumab) Nihon Rinsho. Japanese Journal of Clinical Medicine 65(7): 1239-1242
Kato, S.; Iványi, P.; Lacko, E.; Breur, B.; Du Bois, R.; Eijsvoogel, V.P. 1982: Identification of human CML target. HLA-B locus (B12) antigen variants defined by CTL generated between B locus-identical (B12) responder-stimulator pairs Journal of Immunology 128(2): 949-955